A Customer-Centric Approach to Cell and Gene Therapy Manufacturing
December 7, 2021
Drew Brennan, General Manager, Viral Vector Technologies, at Avid Bioservices, discusses the drivers motivating the company’s entrance into the viral vector space and the unique and differentiating values Avid can offer cell and gene therapy developers.
Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.